<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03845790</url>
  </required_header>
  <id_info>
    <org_study_id>PK PROPHYLAXIE</org_study_id>
    <nct_id>NCT03845790</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Study of Vancomycin, Clindamycin and/or Gentamicin Administration During Surgery Using a Microdialysis Procedure</brief_title>
  <official_title>Pharmacokinetic Study of Vancomycin, Clindamycin and/or Gentamicin Administration During Surgery Using a Microdialysis Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The surgical site infection is one of the most important causes of postoperative morbidity.
      The appropriate antibiotic prophylaxis is one of the most effective way to prevent surgical
      site infections. The beta-lactam are the most frequent antibiotics recommended for surgical
      prophylaxis and patients known to be allergic to beta-lactam are more likely to presented
      surgical site infection, probably due to use of others antibiotic such as vancomycin or
      clindamycin.

      The main objective of the study is to describe the tissu and plasma pharmacokinetics of
      vancomycin, clindamycin and gentamicin using as surgical antibiotic prophylaxis in patients
      with beta-lactam hypersensivity and to predict the probability of target attainment for usual
      bacteria.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2019</start_date>
  <completion_date type="Anticipated">September 26, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 26, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Pharmacokinetic study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total and free plasma of vancomycin, clindamycin or gentamicin</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Free tissue concentration of vancomycin, clindamycin or gentamicin every 20 minutes after the beginning of injections</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Probability of target attainment of PK/PD index for usual bacteria (AUC/CMI &gt;1 for vancomycin and clindamycin, Cmax/CMI &gt;8 for gentamicin) with the recommended dosing regimen</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Probability of target attainment of PK/PD index for usual bacteria (AUC/CMI &gt;1 for vancomycin and clindamycin, Cmax/CMI &gt;8 for gentamicin) with new simulated dosing regimens.</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Surgical Site Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood and microdialysis samples</intervention_name>
    <description>Blood and microdialisys pharmacocinetic samples on one of the two antibiotics prescribed in routine use</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient between 18 and 80 years old

          -  Patient with history of beta-lactam hypersensitivity

          -  Patient who underwent abdominal or orthopedic surgery whose forseeable time exceeds 3
             hours and requires a surgical antibiotic prophylaxis by vancomycin or clindamycin +
             gentamicin

        Exclusion Criteria:

          -  morbid obesity (BMI &gt; 35 kg/m2)

          -  mild to severe renal impairment (clearance creatinine &lt; 60 ml/min)

          -  vancomycin, clindamycin or gentamicin hypersensitivity

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthieu BOISSON</last_name>
    <phone>0033.549.442.517</phone>
    <email>Matthieu.BOISSON@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ARRACHE WASSILA</last_name>
    <phone>0033.549.443.903</phone>
    <email>Wassila.ARRACHE@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthieu Boisson, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>February 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2019</study_first_posted>
  <last_update_submitted>June 12, 2019</last_update_submitted>
  <last_update_submitted_qc>June 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

